In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results
- PMID: 12234865
- PMCID: PMC128790
- DOI: 10.1128/AAC.46.10.3298-3300.2002
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results
Abstract
We studied the effects of inoculum size and incubation time on the susceptibility testing results for various antifungal agents against 22 Fusarium isolates by the NCCLS microdilution method. Increased inoculum size and extended incubation time resulted in elevated MICs. Posaconazole and voriconazole exhibited promising antifungal activities.
Similar articles
-
E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.J Clin Microbiol. 2002 Jun;40(6):2101-7. doi: 10.1128/JCM.40.6.2101-2107.2002. J Clin Microbiol. 2002. PMID: 12037072 Free PMC article.
-
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.J Clin Microbiol. 1999 Dec;37(12):3946-51. doi: 10.1128/JCM.37.12.3946-3951.1999. J Clin Microbiol. 1999. PMID: 10565912 Free PMC article.
-
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.J Clin Microbiol. 2002 Oct;40(10):3841-4. doi: 10.1128/JCM.40.10.3841-3844.2002. J Clin Microbiol. 2002. PMID: 12354895 Free PMC article.
-
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002. Antimicrob Agents Chemother. 2002. PMID: 11897586 Free PMC article.
-
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.J Clin Microbiol. 2002 May;40(5):1694-7. doi: 10.1128/JCM.40.5.1694-1697.2002. J Clin Microbiol. 2002. PMID: 11980944 Free PMC article.
Cited by
-
Fusarium infections in immunocompromised patients.Clin Microbiol Rev. 2007 Oct;20(4):695-704. doi: 10.1128/CMR.00014-07. Clin Microbiol Rev. 2007. PMID: 17934079 Free PMC article. Review.
-
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.Antimicrob Agents Chemother. 2010 Mar;54(3):1055-9. doi: 10.1128/AAC.01445-09. Epub 2010 Jan 11. Antimicrob Agents Chemother. 2010. PMID: 20065054 Free PMC article.
-
Pharmacokinetic/pharmacodynamic profile of posaconazole.Clin Pharmacokinet. 2010 Jun;49(6):379-96. doi: 10.2165/11319340-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20481649 Review.
-
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):615-8. doi: 10.1007/s10096-011-1323-x. Epub 2011 Jul 9. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21744037 No abstract available.
-
Update on the treatment of disseminated fusariosis: Focus on voriconazole.Ther Clin Risk Manag. 2007 Dec;3(6):1165-73. Ther Clin Risk Manag. 2007. PMID: 18516266 Free PMC article.
References
-
- Boutati, E. I., and E. J. Anaissie. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 90:999-1008. - PubMed
-
- Clancy, C. J., and M. H. Nguyen. 1998. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur. J. Clin. Microbiol. Infect. Dis. 17:573-575. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources